Symphogen

Symphogen is a private biopharmaceutical company leading the field of antibody mixtures for therapeutic use in oncology and other significant diseases. Symphogen is dedicated to bringing novel antibody products to the market, creating optimally selected antibody mixtures in a single drug product. The company has collaborations for the development of antibody therapeutics in immuno-oncology with the Shire and the infectious disease area with Genentech. Symphogen was founded in 2000 and is headquartered in Denmark.